Business Wire

DANCHURCHAID

18.3.2024 18:07:34 CET | Business Wire | Press release

Share
Media invitation: World leaders must make headway for adaptation - there are no alternatives

A coalition of international climate organizations will come together for an event in Copenhagen on the 20 March 2024 to deliver recommendations on integrating climate and development for climate finance to world leaders, ahead of a year of intense negotiations, starting at the Copenhagen Climate Ministerial.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240318208761/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Photo: Mathilde Utzon

The year 2024 is of paramount importance for our future. We face an urgent need to handle the climate crisis, within the broader range of Sustainable Development Goals. This year’s high-level meetings leading up to COP29 will focus on climate finance, aiming to address the substantial funding gaps.

To kick-start these discussions DanChurchAid, E3G, the International Institute for Environment and Development, CONCITO, NDC Partnerships, and the UN Foundation are coming together to co-host the virtual and in-person event ‘Integrating Climate and Development for Adaptation Finance in Copenhagen on the 20 March, to provide inspiration for the Copenhagen Climate Summit.

“Adaptation finance must be at the heart of the negotiations towards COP29. Adaptation to the consequences of climate change is a question of survival. We need to adapt to a new reality, where droughts, rising sea levels, and heatwaves are becoming increasingly commonplace,” said Secretary General of DanChurchAid, Jonas Nøddekær.

“The countries most vulnerable to climate change have been clear about what they need to adapt to it - more money, on fairer terms and channelled to local people who are best placed to use it. Governments meeting in Copenhagen have a chance to put down a marker for stronger climate outcomes later this year and to show they're taking lower-income nations seriously,” said Ebony Holland, IIED’s nature-climate policy lead.

“The decisions that governments make this year will shape if, how, and how much finance is delivered over the next decade and beyond. We need to make sure that finance is adequate to achieve the Sustainable Development Goals and a climate resilient future for all,” said Cristina Rumbaitis del Rio, Senior Advisor, Adaptation and Resilience, UN Foundation.

“We must be striving for our climate and development goals concurrently and linking the two. For developing countries, adaptation and resilience are both a priority and a tremendous challenge. The NDC Partnership supports countries efforts to raise ambition in ways that are implementable, financeable and help foster more equitable and sustainable development, through effective coordinated support of more than 220 members,” said Pablo Vieira, Global Director of the NDC Partnership.

“Globally, all stakeholders must come together behind a coherent framework for climate finance as presented by the Independent High-Level Group on Climate Finance to massively upscale funding for integrated climate and development action. Country owned climate plans (NDCs) that integrate adaptation and long-term development plans must be turned into investment plans by 2030,” said Chairperson of the Board of CONCITO, Connie Hedegaard.

“The climate and development ministerials have shone a light on the reforms needed to how we do adaptation finance to shift towards more systemic resilience investments. Denmark, Samoa and their co-champions of the adaptation finance vision agreed at last year’s ministerial have a chance to drive a scale up and improvement in adaptation finance over the next couple of years as countries prepare their next climate policy updates,” said Alex Scott, Climate Diplomacy and Geopolitics Programme Lead at E3G

Event details and registration: The event will take place on the 20 March 2024, from 14:00-16:30, at:
DanChurchAid, Meldahlsgade 3, 1613 Copenhagen V, Denmark.

For registration for either online or in-person participation, please send an email to copenhagenevent@dca.dk

For media request please contact Mattias Söderberg, at: msd@dca.dk or +45 29700609.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240318208761/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release

Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh

Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release

- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur

Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye